Cargando…
Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model
PURPOSE: Inhaled triple therapy (TT) comprising a long-acting muscarinic antagonist, long-acting β(2) agonist, and inhaled corticosteroid is recommended for symptomatic chronic obstructive pulmonary disease (COPD) patients, or those at risk of exacerbation. However, it is not well understood which p...
Autores principales: | Bogart, Michael, Liu, Yuhang, Oakland, Todd, Stiegler, Marjorie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995152/ https://www.ncbi.nlm.nih.gov/pubmed/35418750 http://dx.doi.org/10.2147/COPD.S336297 |
Ejemplares similares
-
Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Wu, Benjamin, et al.
Publicado: (2022) -
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey
por: Mannino, David, et al.
Publicado: (2022) -
The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USA
por: Soler, Xavier, et al.
Publicado: (2022) -
Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss
por: Nikolaou, Vasilis, et al.
Publicado: (2021) -
Machine learning in chronic obstructive pulmonary disease
por: Zhang, Bochao, et al.
Publicado: (2023)